OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
Tibet Duo Rui Pharmaceutical
301075
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
688314 Kontour(Xi'an) Medical Technology
- 27.10
- +0.62+2.34%
Trading Apr 1 14:15 CST
2.20BMarket Cap24.91P/E (TTM)
27.85High26.52Low9.32KlotVolume26.85Open26.48Pre Close25.47MTurnover1.15%Turnover Ratio24.91P/E (Static)81.24MShares35.0052wk High3.46P/B2.20BFloat Cap16.9752wk Low31.78Limit Up81.24MShs Float94.03Historical High21.18Limit Down5.02%Amplitude16.38Historical Low0.50Dividend TTM27.32Avg Price3.48KlotAsk1.85%Div YieldTTM100Lot Size5.76KlotBid
Kontour(Xi'an) Medical Technology Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 17.06%321.95M | 16.22%240.12M | 13.48%153.34M | 8.16%69.92M | 14.62%275.03M | 15.76%206.6M | 17.10%135.13M | 20.82%64.64M | 12.89%239.95M | 18.16%178.48M |
| Operating revenue | 17.06%321.95M | 16.22%240.12M | 13.48%153.34M | 8.16%69.92M | 14.62%275.03M | 15.76%206.6M | 17.10%135.13M | 20.82%64.64M | 12.89%239.95M | 18.16%178.48M |
| Interest income | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Commission income | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Premiums earned | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Total operating cost | 18.34%210.82M | 14.68%148.31M | 10.46%96.23M | 6.84%44.39M | 15.26%178.16M | 23.48%129.33M | 27.76%87.12M | 30.44%41.55M | 19.01%154.57M | 24.06%104.73M |
| Operating cost | 24.56%64.46M | 21.01%47.22M | 19.39%30.52M | 9.57%13.13M | 16.41%51.75M | 17.12%39.02M | 16.58%25.56M | 3.31%11.98M | 20.35%44.46M | 27.10%33.32M |
| Operating tax surcharges | 8.11%5.23M | 3.28%3.83M | 8.75%2.63M | 1.79%1.19M | 17.83%4.84M | 18.98%3.71M | 24.41%2.42M | 31.87%1.17M | 47.35%4.11M | 92.71%3.12M |
| Operating expense | 15.75%63.73M | 9.75%44.86M | 0.19%28.84M | -1.24%13.05M | 15.89%55.06M | 38.08%40.88M | 55.64%28.78M | 75.82%13.21M | 32.80%47.51M | 22.05%29.6M |
| Administration expense | 7.19%56.04M | 9.63%38.71M | 7.11%25.15M | 7.38%13.02M | 18.63%52.28M | 12.74%35.31M | 14.87%23.49M | 25.79%12.12M | 11.83%44.07M | 22.27%31.32M |
| Financial expense | 25.48%-2.54M | 18.40%-2.72M | 29.59%-993.24K | 30.73%-648.7K | 11.96%-3.41M | 11.27%-3.33M | -123.46%-1.41M | -255.64%-936.54K | -111.81%-3.87M | -148.42%-3.75M |
| -Interest expense (Financial expense) | 14.86%2.17M | 21.07%1.69M | 30.61%1.16M | 38.28%541.66K | 54.25%1.89M | 55.28%1.4M | 55.03%890.64K | 52.69%391.71K | 65.74%1.23M | 166.47%899.01K |
| -Interest Income (Financial expense) | -0.43%-5.22M | -7.89%-4.89M | -23.11%-2.39M | -3.15%-1.39M | -10.84%-5.2M | -11.69%-4.53M | -79.51%-1.94M | -117.48%-1.35M | -74.48%-4.69M | -104.31%-4.06M |
| Research and development | 35.53%23.9M | 19.40%16.4M | 21.71%10.07M | 16.37%4.66M | -3.63%17.64M | 23.49%13.73M | 37.73%8.28M | 61.23%4M | 8.90%18.3M | 35.17%11.12M |
| Credit Impairment Loss | -675.97%-1.27M | 617.17%98.34K | 51.34%-66.49K | 16,765.24%226.87K | 49.14%-163.97K | 86.52%-19.02K | 17.85%-136.64K | 88.07%-1.36K | -1,435.97%-322.42K | -275.74%-141.07K |
| Asset Impairment Loss | 38.10%-5.34M | 33.09%-2.41M | -9.62%-2.11M | 0.02%-587.26K | -50.40%-8.63M | -27.96%-3.6M | 21.10%-1.92M | 29.30%-587.38K | -13.64%-5.74M | 22.38%-2.81M |
| Other net revenue | ||||||||||
| Fair value change income | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Invest income | -575.32%-12.59M | -3,036.03%-8.12M | -3,968.51%-5.12M | -1,296.13%-2.2M | -153.98%-1.86M | -111.44%-258.87K | -91.05%132.45K | -29.59%184.06K | 60.08%3.45M | 374.59%2.26M |
| Net open hedge income | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | --0 | ---- |
| -Including: Investment income associates | -186.94%-14.8M | -299.88%-9.48M | -512.49%-5.96M | ---2.34M | ---5.16M | ---2.37M | ---972.86K | ---- | --0 | ---- |
| Exchange income | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Asset deal income | 1,411.37%463.92K | 1,219.33%395.98K | 1,219.33%395.98K | ---- | -1,091.43%-35.38K | ---35.38K | ---35.38K | ---- | -113.16%-2.97K | ---- |
| Other revenue | 153.69%13.33M | 195.07%10.2M | 817.49%8.84M | 91.87%1.32M | 47.50%5.25M | -9.78%3.46M | 249.87%963.08K | 285.59%685.5K | -45.25%3.56M | 9.54%3.83M |
| Operating profit | 15.62%105.71M | 19.73%91.97M | 25.61%59.05M | 3.88%24.28M | 5.91%91.43M | -0.09%76.82M | 1.41%47.01M | 10.02%23.37M | 0.01%86.33M | 14.65%76.89M |
| Add:Non operating Income | 14.46%537.5K | 43.94%392.61K | 2,453.22%237.22K | -99.99%0.99 | -79.72%469.57K | 11,248.04%272.76K | 334.03%9.29K | 280.26%8.14K | -75.65%2.32M | -99.95%2.4K |
| Less:Non operating expense | 65.69%247.98K | -0.37%34.77K | -57.59%14.79K | ---- | -17.81%149.67K | -80.80%34.9K | -62.09%34.87K | --0.02 | -58.82%182.11K | --181.78K |
| Total profit | 15.53%106M | 19.83%92.33M | 26.15%59.27M | 3.85%24.28M | 3.72%91.75M | 0.45%77.05M | 1.55%46.98M | 10.05%23.38M | -7.26%88.46M | 6.44%76.71M |
| Less:Income tax cost | 6.30%18.37M | 21.74%16.33M | 30.77%10.99M | 8.30%4.66M | 20.80%17.28M | 3.37%13.41M | 4.57%8.41M | 17.31%4.3M | 0.67%14.3M | 22.93%12.97M |
| Net profit | 17.67%87.64M | 19.42%76.01M | 25.14%48.28M | 2.84%19.62M | 0.42%74.47M | -0.14%63.64M | 0.91%38.58M | 8.54%19.08M | -8.65%74.16M | 3.61%63.73M |
| Net profit from continuing operation | 17.67%87.64M | 19.42%76.01M | 25.14%48.28M | 2.84%19.62M | 0.42%74.47M | -0.14%63.64M | 0.91%38.58M | 8.54%19.08M | -8.65%74.16M | 3.61%63.73M |
| Net income from discontinuing operating | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Less:Minority Profit | 26.48%-763.15K | -0.58%-706.89K | 14.43%-515.87K | 7.99%-313.55K | 32.06%-1.04M | 39.64%-702.82K | 34.06%-602.89K | 24.86%-340.79K | -244.12%-1.53M | -196.66%-1.16M |
| Net profit of parent company owners | 17.07%88.4M | 19.22%76.71M | 24.53%48.79M | 2.65%19.94M | -0.23%75.51M | -0.85%64.35M | 0.10%39.18M | 7.70%19.42M | -7.28%75.69M | 4.84%64.9M |
| Earning per share | ||||||||||
| Basic earning per share | 17.20%1.09 | 18.99%0.94 | 25.00%0.6 | 4.17%0.25 | 0.00%0.93 | -1.25%0.79 | 0.00%0.48 | -22.58%0.24 | -40.76%0.93 | -35.48%0.8 |
| Diluted earning per share | 17.20%1.09 | 18.99%0.94 | 25.00%0.6 | 4.17%0.25 | 0.00%0.93 | -1.25%0.79 | 0.00%0.48 | -22.58%0.24 | -40.76%0.93 | -35.48%0.8 |
| Other composite income | -18.49%-556.79K | -719.81%-641.68K | -259.71%-367.84K | -106.11%-401.09K | -130.45%-469.9K | -93.96%103.53K | -51.95%230.32K | -124.23%-194.59K | 520.98%1.54M | 2,892.51%1.72M |
| Other composite income of parent company owners | -20.28%-540.29K | -581.64%-653.01K | -229.13%-362.34K | -95.27%-399.09K | -128.78%-449.2K | -92.24%135.58K | -44.80%280.59K | -132.29%-204.38K | 523.64%1.56M | 2,974.40%1.75M |
| Other composite income of minority owners | 20.29%-16.5K | 135.34%11.33K | 89.07%-5.5K | -120.45%-2K | -18.26%-20.7K | 0.76%-32.05K | -73.54%-50.27K | 714.63%9.78K | -1,055.23%-17.5K | -6,880.71%-32.3K |
| Total composite income | 17.67%87.08M | 18.22%75.36M | 23.45%47.91M | 1.78%19.22M | -2.25%74M | -2.60%63.75M | 0.26%38.81M | 7.96%18.88M | -6.33%75.7M | 6.30%65.45M |
| Total composite income of parent company owners | 17.05%87.86M | 17.96%76.06M | 22.73%48.43M | 1.67%19.54M | -2.83%75.06M | -3.25%64.48M | -0.48%39.46M | 7.09%19.22M | -4.93%77.25M | 7.56%66.65M |
| Total composite income of minority owners | 26.36%-779.65K | 5.35%-695.56K | 20.18%-521.37K | 4.67%-315.55K | 31.49%-1.06M | 38.59%-734.87K | 30.75%-653.16K | 26.83%-331.01K | -249.50%-1.55M | -205.26%-1.2M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | -- | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
